155 related articles for article (PubMed ID: 38062709)
1. Genomic Characteristics and Its Therapeutic Implications in Breast Cancer Patients with Detectable Molecular Residual Disease.
Zhang S; Jiang Y; Zhou L; Xu J; Zhang G; Shen L; Xu Y
Cancer Res Treat; 2024 Apr; 56(2):538-548. PubMed ID: 38062709
[TBL] [Abstract][Full Text] [Related]
2. Repertoire Sequencing of B Cells Elucidates the Role of UNG and Mismatch Repair Proteins in Somatic Hypermutation in Humans.
IJspeert H; van Schouwenburg PA; Pico-Knijnenburg I; Loeffen J; Brugieres L; Driessen GJ; Blattmann C; Suerink M; Januszkiewicz-Lewandowska D; Azizi AA; Seidel MG; Jacobs H; van der Burg M
Front Immunol; 2019; 10():1913. PubMed ID: 31507588
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerases β and λ do not directly affect Ig variable region somatic hypermutation although their absence reduces the frequency of mutations.
Schrader CE; Linehan EK; Ucher AJ; Bertocci B; Stavnezer J
DNA Repair (Amst); 2013 Dec; 12(12):1087-93. PubMed ID: 24084171
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
Bentivegna S; Zheng J; Namsaraev E; Carlton VE; Pavlicek A; Moorhead M; Siddiqui F; Wang Z; Lee L; Ireland JS; Suyenaga K; Willis TD; Faham M; Seymour AB
Hum Mutat; 2008 Mar; 29(3):441-50. PubMed ID: 18186519
[TBL] [Abstract][Full Text] [Related]
5. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
Pilzecker B; Jacobs H
Front Immunol; 2019; 10():438. PubMed ID: 30915081
[TBL] [Abstract][Full Text] [Related]
6. Altered spectrum of somatic hypermutation in common variable immunodeficiency disease characteristic of defective repair of mutations.
Duvvuri B; Duvvuri VR; Grigull J; Martin A; Pan-Hammarström Q; Wu GE; Larijani M
Immunogenetics; 2011 Jan; 63(1):1-11. PubMed ID: 20938659
[TBL] [Abstract][Full Text] [Related]
7. Expression of human AID in yeast induces mutations in context similar to the context of somatic hypermutation at G-C pairs in immunoglobulin genes.
Mayorov VI; Rogozin IB; Adkison LR; Frahm C; Kunkel TA; Pavlov YI
BMC Immunol; 2005 Jun; 6():10. PubMed ID: 15949042
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC
Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088
[TBL] [Abstract][Full Text] [Related]
9. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.
Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA
Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691
[TBL] [Abstract][Full Text] [Related]
10. Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non-small cell lung cancer patients.
Li H; Ma ZL; Li B; Pan YJ; Xiang JQ; Zhang YW; Sun YH; Hou T; Lizaso A; Chen Y; Li X; Hu H
Cancer Med; 2021 Dec; 10(23):8377-8386. PubMed ID: 34664796
[TBL] [Abstract][Full Text] [Related]
11. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
12. A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets.
Álvarez-Prado ÁF; Pérez-Durán P; Pérez-García A; Benguria A; Torroja C; de Yébenes VG; Ramiro AR
J Exp Med; 2018 Mar; 215(3):761-771. PubMed ID: 29374026
[TBL] [Abstract][Full Text] [Related]
13. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination.
Zan H; Zhang J; Ardeshna S; Xu Z; Park SR; Casali P
Autoimmunity; 2009 Feb; 42(2):89-103. PubMed ID: 19156553
[TBL] [Abstract][Full Text] [Related]
14. Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer.
Tarazona N; Gimeno-Valiente F; Gambardella V; Zuñiga S; Rentero-Garrido P; Huerta M; Roselló S; Martinez-Ciarpaglini C; Carbonell-Asins JA; Carrasco F; Ferrer-Martínez A; Bruixola G; Fleitas T; Martín J; Tébar-Martínez R; Moro D; Castillo J; Espí A; Roda D; Cervantes A
Ann Oncol; 2019 Nov; 30(11):1804-1812. PubMed ID: 31562764
[TBL] [Abstract][Full Text] [Related]
15. The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer.
Yang Y; Zhang J; Li JY; Xu L; Wang SN; Zhang JQ; Xun Z; Xia Y; Cao JB; Liu Y; Shi LY; Li W; Shi YL; He YG; Gu DJ; Yu ZY; Chen K; Lan J
Gland Surg; 2022 Dec; 11(12):1924-1935. PubMed ID: 36654951
[TBL] [Abstract][Full Text] [Related]
16. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
Steele EJ
DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
[TBL] [Abstract][Full Text] [Related]
17. Somatic hypermutation of immunoglobulin genes in Rad18 knockout mice.
Shimizu T; Tateishi S; Tanoue Y; Azuma T; Ohmori H
DNA Repair (Amst); 2017 Feb; 50():54-60. PubMed ID: 28082021
[TBL] [Abstract][Full Text] [Related]
18. Perioperative ctDNA-Based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1).
Xia L; Mei J; Kang R; Deng S; Chen Y; Yang Y; Feng G; Deng Y; Gan F; Lin Y; Pu Q; Ma L; Lin F; Yuan Y; Hu Y; Guo C; Liao H; Liu C; Zhu Y; Wang W; Liu Z; Xu Y; Li K; Li C; Li Q; He J; Chen W; Zhang X; Kou Y; Wang Y; Wu Z; Che G; Chen L; Liu L
Clin Cancer Res; 2022 Aug; 28(15):3308-3317. PubMed ID: 34844976
[TBL] [Abstract][Full Text] [Related]
19. Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
Chauhan PS; Chen K; Babbra RK; Feng W; Pejovic N; Nallicheri A; Harris PK; Dienstbach K; Atkocius A; Maguire L; Qaium F; Szymanski JJ; Baumann BC; Ding L; Cao D; Reimers MA; Kim EH; Smith ZL; Arora VK; Chaudhuri AA
PLoS Med; 2021 Aug; 18(8):e1003732. PubMed ID: 34464379
[TBL] [Abstract][Full Text] [Related]
20. Apurinic/apyrimidinic endonuclease 1 (APE1) is dispensable for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation in the immunoglobulin gene.
Islam H; Kobayashi M; Honjo T
Int Immunol; 2019 Jul; 31(8):543-554. PubMed ID: 30877298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
